Hospital CEOs Warn 340B Rebate Pilot Could Strain Cash Flow
Becker's Hospital Review reports that hospital CEOs are closely watching a limited federal rebate pilot set to begin January 1, 2027, that would change how some 340B drug discounts are delivered. Currently, eligible hospitals receive 340B discounts upfront at the point of purchase; the pilot would instead require hospitals to pay full price and later receive a rebate, delaying access to discount funds. CEOs interviewed say this shift could affect hospital cash flow and staffing decisions, particularly for safety-net and disproportionate-share hospitals that rely on 340B savings to fund operations. The change comes amid ongoing legal challenges to the 340B program's administration.
Hospitals that depend on upfront 340B savings to cover operating costs and staffing need to plan now for a cash-flow gap if the rebate model takes effect, since delayed reimbursement could strain budgets tied to Medicaid and uninsured patient care.
Pharmacy · Finance
You might also like